These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10653271)

  • 1. Primary and secondary prevention using lipid-lowering therapies.
    Holm K
    J Cardiovasc Nurs; 2000 Jan; 14(2):1-8. PubMed ID: 10653271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying patients at risk for coronary heart disease: implications from trials of lipid-lowering drug therapy.
    Isles CG; Paterson JR
    QJM; 2000 Sep; 93(9):567-74. PubMed ID: 10984551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin improves blood lipid pattern in nondiabetic patients with coronary heart disease.
    Carlsen SM; Rossvoll O; Bjerve KS; Følling I
    J Intern Med; 1996 Mar; 239(3):227-33. PubMed ID: 8772621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trials of lipid-lowering therapy in primary prevention of coronary heart disease.
    Jones PH
    Curr Opin Lipidol; 1995 Dec; 6(6):365-8. PubMed ID: 8750249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid-lowering drugs in the management of hyperlipidaemia.
    Bhatnagar D
    Pharmacol Ther; 1998 Sep; 79(3):205-30. PubMed ID: 9776377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary prevention of ischaemic heart disease with lipid-lowering drugs.
    Lancet; 1988 Feb; 1(8581):333-4. PubMed ID: 2893141
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined intense lifestyle and pharmacologic lipid treatment further reduce coronary events and myocardial perfusion abnormalities compared with usual-care cholesterol-lowering drugs in coronary artery disease.
    Sdringola S; Nakagawa K; Nakagawa Y; Yusuf SW; Boccalandro F; Mullani N; Haynie M; Hess MJ; Gould KL
    J Am Coll Cardiol; 2003 Jan; 41(2):263-72. PubMed ID: 12535820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspectives in the treatment of dyslipidemias in the prevention of coronary heart disease.
    Borgia MC; Medici F
    Angiology; 1998 May; 49(5):339-48. PubMed ID: 9591525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of diabetic dyslipidemia.
    Garg A
    Am J Cardiol; 1998 Feb; 81(4A):47B-51B. PubMed ID: 9526814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Best practice--ongoing polemics.
    Paoletti R; Bellosta S
    Atherosclerosis; 1999 May; 143 Suppl 1():S3-6. PubMed ID: 10382831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of coronary heart disease. Part I. Primary prevention.
    Liebson PR; Amsterdam EA
    Dis Mon; 1999 Dec; 45(12):497-571. PubMed ID: 10711300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ineffectiveness of lipid-lowering therapy in primary care.
    Van Ganse E; Souchet T; Laforest L; Moulin P; Bertrand M; Le Jeunne P; Travier N; Yin D; Alemao E; de Pouvourville G
    Br J Clin Pharmacol; 2005 Apr; 59(4):456-63. PubMed ID: 15801941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid-lowering drugs.
    Milander MM; Kuhn M
    AACN Clin Issues Crit Care Nurs; 1992 May; 3(2):494-506. PubMed ID: 1576043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of appropriate type and intensity of lipid-lowering therapy.
    Tikkanen MJ
    Curr Opin Lipidol; 1995 Dec; 6(6):360-4. PubMed ID: 8750248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal management of cholesterol levels and the prevention of coronary heart disease in women.
    Mosca LJ
    Am Fam Physician; 2002 Jan; 65(2):217-26. PubMed ID: 11820486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention of coronary heart disease by therapy of hyperlipidemia. Between cholesterol hysteria and therapeutic realism].
    Deller M; Huth K
    Fortschr Med; 1992 Sep; 110(25):463-6. PubMed ID: 1398397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale for treatment.
    Gotto AM
    Am J Med; 1991 Jul; 91(1B):31S-36S. PubMed ID: 1867234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Coronary risk in Spain and its treatment with lipid-lowering drugs].
    Maiques Galán A; Villar Alvarez F; Llor Vila C; Torcal Laguna J
    Aten Primaria; 2003 Oct; 32(7):420-2. PubMed ID: 14622555
    [No Abstract]   [Full Text] [Related]  

  • 19. Current lipid management and low cholesterol goal attainment in common daily practice in Spain. The REALITY Study.
    García Ruiz FJ; Marín Ibáñez A; Pérez-Jiménez F; Pintó X; Nocea G; Ahumada C; Alemao E; Yin D;
    Pharmacoeconomics; 2004; 22 Suppl 3():1-12. PubMed ID: 15669149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid-lowering drug use and cardiovascular events after myocardial infarction.
    Klungel OH; Heckbert SR; de Boer A; Leufkens HG; Sullivan SD; Fishman PA; Veenstra DL; Psaty BM
    Ann Pharmacother; 2002 May; 36(5):751-7. PubMed ID: 11978147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.